Selegiline hydrochloride is a selective, irreversible monoamine oxidase-B (MAO-B) inhibitor categorized as a phenethylamine derivative, widely utilized as an adjunctive therapy in the management of Parkinson's… Read more
Selegiline hydrochloride is a selective, irreversible monoamine oxidase-B (MAO-B) inhibitor categorized as a phenethylamine derivative, widely utilized as an adjunctive therapy in the management of Parkinson's disease. By preventing the oxidative deamination of dopamine, this agent enhances the efficacy of levodopa and helps maintain neurotransmitter levels within the central nervous system. Laboratories requiring precision in their analytical workflows utilize high-quality Selegiline hydrochloride reference standards, including pharmacopeial and non-pharmacopeial impurities, to ensure accurate impurity profiling and method validation. Furthermore, stable isotope-labelled compounds of this drug are critical for reliable quantification in bioanalytical assays. These analytical materials support comprehensive quality control procedures, enabling the rigorous testing required during pharmaceutical development and regulatory compliance to monitor related substances and degradants effectively.